Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Oncology
3
Pipeline Programs
3
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
3100%

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Genomics
GenomicsUK - Oxford
1 program
1
IadademstatPhase 1Small Molecule1 trial
Active Trials
NCT07113691Recruiting15Est. Jan 2030
Oryzon Genomics
Oryzon GenomicsMA - Cambridge
1 program
1
IadademstatPhase 1Small Molecule
Genentech
GenentechCA - Oceanside
1 program
1
IadademstatPhase 1Small Molecule

Trial Timeline

Clinical trial activity over time

2026
2027
2028
2029
2030
GenomicsIadademstat

Clinical Trials (1)

Total enrollment: 15 patients across 1 trials

Iadademstat + SBRT With Atezo in ES-SCLC

Start: Jan 2026Est. completion: Jan 203015 patients
Phase 1Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 15 patients
3 companies competing in this space